Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2018

30.07.2018 | Clinical trial

Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study

verfasst von: Tara Sanft, Ilana Usiskin, Maura Harrigan, Brenda Cartmel, Lingeng Lu, Fang-Yong Li, Yang Zhou, Anees Chagpar, Leah M. Ferrucci, Lajos Pusztai, Melinda L. Irwin

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Some studies suggest that telomere shortening may be associated with increased breast cancer risk and mortality. Obesity is also associated with increased breast cancer risk and mortality. Few studies have examined changes in telomere length in overweight or obese breast cancer survivors. The purpose of our study was to examine the effect of a 6-month diet- and exercise-induced weight loss intervention versus usual care on telomere length in breast cancer survivors.

Methods

151 breast cancer survivors with body mass index (BMI) ≥ 25 kg/m2 were randomly assigned to a 6-month weight loss intervention (n = 93) or to usual care (n = 58). Fasting blood samples, height, weight, physical activity, and diet were measured at baseline and 6-months. Relative telomere length (RTL) was measured by quantitative-polymerase chain reaction (qPCR) done on buffy coat-extracted genomic DNA. Mean baseline to 6-month changes were compared between groups (intention-to-treat) using generalized estimating equations.

Results

Complete telomere data were available in 125 participants. Women were 58 ± 8 years, with BMI 33.0 ± 6.2 kg/m2 and were 2.9 ± 2.5 years from diagnosis; 90% were non-Hispanic white, and 76% had stage 0/I breast cancer. After 6 months, women randomized to weight loss had 3% telomere lengthening compared to 5% shortening in the usual care group (p = 0.12). Among women with stage 0/I, the intervention group experienced 7% telomere lengthening compared to 8% shortening in the usual care group (p = 0.01). No intervention effect was observed in women with stage II/III breast cancer.

Conclusion

Our findings suggest a weight loss intervention in stage 0 and 1 breast cancer survivors may lead to telomere lengthening, compared to a shortening in their usual care counterparts.
Literatur
1.
Zurück zum Zitat Lu W, Zhang Y, Liu D et al (2013) Telomeres-structure, function, and regulation. Exp Cell Res 319:133–141CrossRef Lu W, Zhang Y, Liu D et al (2013) Telomeres-structure, function, and regulation. Exp Cell Res 319:133–141CrossRef
2.
Zurück zum Zitat Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177–208CrossRef Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177–208CrossRef
3.
Zurück zum Zitat McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331–358CrossRef McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331–358CrossRef
4.
Zurück zum Zitat Buxton JL, Suderman M, Pappas JJ et al (2014) Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep 4:4954CrossRef Buxton JL, Suderman M, Pappas JJ et al (2014) Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep 4:4954CrossRef
5.
Zurück zum Zitat Risques RA, Vaughan TL, Li X et al (2007) Leukocyte telomere length predicts cancer risk in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 16:2649–2655CrossRef Risques RA, Vaughan TL, Li X et al (2007) Leukocyte telomere length predicts cancer risk in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 16:2649–2655CrossRef
6.
Zurück zum Zitat Mirabello L, Garcia-Closas M, Cawthon R et al (2010) Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 21:77–82CrossRef Mirabello L, Garcia-Closas M, Cawthon R et al (2010) Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 21:77–82CrossRef
7.
Zurück zum Zitat Wentzensen IM, Mirabello L, Pfeiffer RM et al (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1238–1250CrossRef Wentzensen IM, Mirabello L, Pfeiffer RM et al (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1238–1250CrossRef
8.
Zurück zum Zitat Gramatges MM, Telli ML, Balise R et al (2010) Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 19:605–613CrossRef Gramatges MM, Telli ML, Balise R et al (2010) Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 19:605–613CrossRef
9.
Zurück zum Zitat De Vivo I, Prescott J, Wong JY et al (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1152–1156CrossRef De Vivo I, Prescott J, Wong JY et al (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1152–1156CrossRef
10.
Zurück zum Zitat Shen J, Gammon MD, Terry MB et al (2009) Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 124:1637–1643CrossRef Shen J, Gammon MD, Terry MB et al (2009) Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 124:1637–1643CrossRef
11.
Zurück zum Zitat Shen J, Terry MB, Gurvich I et al (2007) Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538–5544CrossRef Shen J, Terry MB, Gurvich I et al (2007) Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538–5544CrossRef
12.
Zurück zum Zitat Ma H, Zhou Z, Wei S et al (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 6:e20466CrossRef Ma H, Zhou Z, Wei S et al (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 6:e20466CrossRef
13.
Zurück zum Zitat Duggan C, Risques R, Alfano C et al (2014) Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst 106:dju035CrossRef Duggan C, Risques R, Alfano C et al (2014) Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst 106:dju035CrossRef
14.
Zurück zum Zitat Nordfjall K, Eliasson M, Stegmayr B et al (2008) Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 16:2682–2689CrossRef Nordfjall K, Eliasson M, Stegmayr B et al (2008) Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 16:2682–2689CrossRef
15.
Zurück zum Zitat Kim S, Parks CG, DeRoo LA et al (2009) Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 18:816–820CrossRef Kim S, Parks CG, DeRoo LA et al (2009) Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 18:816–820CrossRef
16.
Zurück zum Zitat Muezzinler A, Zaineddin AK, Brenner H (2014) Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis. Obes Rev 15:192–201CrossRef Muezzinler A, Zaineddin AK, Brenner H (2014) Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis. Obes Rev 15:192–201CrossRef
17.
Zurück zum Zitat Cui Y, Gao YT, Cai Q et al (2013) Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women. Obesity (Silver Spring) 21:2582–2588CrossRef Cui Y, Gao YT, Cai Q et al (2013) Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women. Obesity (Silver Spring) 21:2582–2588CrossRef
18.
Zurück zum Zitat Carulli L, Anzivino C, Baldelli E et al (2016) Telomere length elongation after weight loss intervention in obese adults. Mol Genet Metab 118:138–142CrossRef Carulli L, Anzivino C, Baldelli E et al (2016) Telomere length elongation after weight loss intervention in obese adults. Mol Genet Metab 118:138–142CrossRef
19.
Zurück zum Zitat Mason C, Risques RA, Xiao L et al (2013) Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21:E549–E554CrossRef Mason C, Risques RA, Xiao L et al (2013) Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21:E549–E554CrossRef
20.
Zurück zum Zitat Garcia-Calzon S, Moleres A, Marcos A et al (2014) Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON study. PLoS ONE 9:e89828CrossRef Garcia-Calzon S, Moleres A, Marcos A et al (2014) Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: the EVASYON study. PLoS ONE 9:e89828CrossRef
21.
Zurück zum Zitat Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14:1112–1120CrossRef Ornish D, Lin J, Chan JM et al (2013) Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14:1112–1120CrossRef
22.
Zurück zum Zitat Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34:669–676CrossRef Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34:669–676CrossRef
23.
Zurück zum Zitat Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21CrossRef Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21CrossRef
24.
Zurück zum Zitat Lan Q, Cawthon R, Gao Y et al (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 8:e59230CrossRef Lan Q, Cawthon R, Gao Y et al (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 8:e59230CrossRef
25.
Zurück zum Zitat Ennour-Idrissi K, Maunsell E, Diorio C (2017) Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomarkers Prev 26:3–10CrossRef Ennour-Idrissi K, Maunsell E, Diorio C (2017) Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomarkers Prev 26:3–10CrossRef
26.
Zurück zum Zitat Zheng YL, Ambrosone C, Byrne C et al (2010) Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 120:769–775CrossRef Zheng YL, Ambrosone C, Byrne C et al (2010) Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 120:769–775CrossRef
27.
Zurück zum Zitat Zheng YL, Loffredo CA, Shields PG et al (2009) Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 30:1380–1386CrossRef Zheng YL, Loffredo CA, Shields PG et al (2009) Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 30:1380–1386CrossRef
28.
Zurück zum Zitat Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16:413CrossRef Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16:413CrossRef
29.
Zurück zum Zitat Cherkas LF, Hunkin JL, Kato BS et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168:154–158CrossRef Cherkas LF, Hunkin JL, Kato BS et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168:154–158CrossRef
Metadaten
Titel
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study
verfasst von
Tara Sanft
Ilana Usiskin
Maura Harrigan
Brenda Cartmel
Lingeng Lu
Fang-Yong Li
Yang Zhou
Anees Chagpar
Leah M. Ferrucci
Lajos Pusztai
Melinda L. Irwin
Publikationsdatum
30.07.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4895-7

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research and Treatment 1/2018 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.